Russell Investments Group, Ltd. Glaukos Corp Transaction History

Russell Investments Group, Ltd.

$69.8 Billion
Q4 2024

A detailed history of Russell Investments Group, Ltd. transactions in Glaukos Corp stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 13,965 shares of GKOS stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,965

Previous 12,102 15.39%

Holding current value

$1.76 Million

Previous $1.58 Million 32.8%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$126.42 - $152.67 $235,520 - $284,424	1,863 Added 15.39%	13,965 $2.09 Million
Q3 2024 Nov 13, 2024	BUY	$113.62 - $135.39 $75,670 - $90,169	666 Added 5.82%	12,102 $1.58 Million
Q2 2024 Aug 08, 2024	BUY	$89.48 - $118.35 $4,384 - $5,799	49 Added 0.43%	11,436 $1.35 Million
Q1 2024 May 08, 2024	SELL	$76.4 - $96.33 $496,905 - $626,530	-6,504 Reduced 36.35%	11,387 $1.07 Million
Q4 2023 Feb 05, 2024	BUY	$59.53 - $85.11 $161,623 - $231,073	2,715 Added 17.89%	17,891 $1.42 Million
Q3 2023 Nov 13, 2023	BUY	$69.23 - $79.09 $1.05 Million - $1.2 Million	15,139 Added 40916.22%	15,176 $1.14 Million
Q2 2023 Aug 10, 2023	BUY	$45.44 - $71.21 $1,681 - $2,634	37 New	37 $2,000
Q3 2021 Nov 08, 2021	SELL	$47.43 - $84.23 $83,856 - $148,918	-1,768 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$70.43 - $97.42 $124,520 - $172,238	1,768 New	1,768 $148,000
Q4 2020 Feb 08, 2021	SELL	$48.9 - $75.26 $86,455 - $133,059	-1,768 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$28.78 - $46.83 $10,015 - $16,296	-348 Reduced 16.45%	1,768 $67,000
Q1 2020 May 06, 2020	SELL	$25.53 - $70.14 $27,955 - $76,803	-1,095 Reduced 34.1%	2,116 $65,000
Q4 2019 Jan 29, 2020	SELL	$54.18 - $65.64 $644,091 - $780,328	-11,888 Reduced 78.73%	3,211 $174,000
Q3 2019 Nov 01, 2019	BUY	$58.58 - $83.91 $884,499 - $1.27 Million	15,099 New	15,099 $943,000
Q2 2019 Aug 09, 2019	SELL	$63.59 - $78.71 $4.06 Million - $5.02 Million	-63,813 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$50.75 - $80.54 $3.24 Million - $5.14 Million	63,813 New	63,813 $5 Million
Q4 2018 Feb 11, 2019	SELL	$52.18 - $67.93 $844,846 - $1.1 Million	-16,191 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$38.13 - $68.37 $107,374 - $192,529	-2,816 Reduced 14.82%	16,191 $1.05 Million
Q2 2018 Aug 08, 2018	SELL	$27.62 - $44.51 $75,043 - $120,933	-2,717 Reduced 12.51%	19,007 $772,000
Q1 2018 May 11, 2018	SELL	$26.05 - $34.5 $180,396 - $238,912	-6,925 Reduced 24.17%	21,724 $670,000
Q4 2017 Feb 06, 2018	BUY	$24.5 - $36.01 $489,436 - $719,371	19,977 Added 230.36%	28,649 $746,000
Q3 2017 Nov 07, 2017	BUY	$31.26 - $42.03 $271,086 - $364,484	8,672	8,672 $286,000

Others Institutions Holding GKOS

# of Institutions

354

Shares Held

50M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $5.99B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Glaukos Corp Transaction History